Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05440539 · ClinicalTrials.gov registry record · NA

Educating Women About Pelvic Floor Disorders During Pregnancy

A NA study, sponsored by The Methodist Hospital Research Institute.

Completed
Registry status
NA
Development phase
120
Enrollment target

NCT05440539: Completed NA study, sponsored by The Methodist Hospital Research Institute.

NCT05440539 is a NA study that has completed, run by The Methodist Hospital Research Institute. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05440539, a NA study, has completed, sponsored by The Methodist Hospital Research Institute.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target

Study Summary

The purpose of this study is to assess the increase in knowledge of pregnant patients regarding pelvic floor disorders when comparing two educational interventions: written handouts vs interactive workshops.

Primary Outcome

Validated 24 question questionnaire with two sections to test knowledge on pelvic organ prolapse and urinary incontinence. Scored out of 24 with higher scores indicating an increase in knowledge. Minimum value: 0, Maximum value: 24. Higher scores mean better outcome. Lower scores mean worse outcome. This was administrated at time of recruitment and again at 6 weeks postpartum.

Interventions

  • OTHER Written Handouts
  • OTHER Interactive Workshop

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2020-08-01
Est. Completion 2021-09-10
Phase NA

What the finished NCT05440539 record still lists

NCT05440539 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 2 interventions - of which Written Handouts is the first listed.

NCT05440539 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05440539 about?

NCT05440539 is a clinical study titled "Educating Women About Pelvic Floor Disorders During Pregnancy". The purpose of this study is to assess the increase in knowledge of pregnant patients regarding pelvic floor disorders when comparing two educational interventions: written handouts vs interactive workshops.

What is the current status of trial NCT05440539?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2020-08-01. Estimated completion is 2021-09-10.

What interventions are being tested in trial NCT05440539?

The interventions under investigation include: Written Handouts (OTHER), Interactive Workshop (OTHER).

Who is sponsoring clinical trial NCT05440539?

This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05440539's enrollment target sits among peer trials

120 762nd of 2000 higher than 1,198 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05440539, the US trial registry maintained by the National Library of Medicine. NCT05440539 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.